The Challenges With Shipping Cell Therapy Products
Source: Cell & Gene
Murphy’s law theorizes that if anything can go wrong, it will. This is especially true when it comes to transporting cellular products. In this segment from the Cell & Gene Live digital event Stem-Cell Derived Therapies: From Source To Site, panelists Michael Mehler from ZS consulting and Dr. Colleen Delaney from Deverra Therapeutics and Coeptis Therapeutics share some of the worst-case shipping scenarios they’ve encountered — from failed temperature loggers to damaged packaging and improperly frozen products.
access the Video!
Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue.
X
Enter your credentials below to log in. Not yet a member of Cell & Gene? Subscribe today.
Subscribe to Cell & Gene
X
Subscribe to Cell & Gene
This website uses cookies to ensure you get the best experience on our website. Learn more